Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Magali Gilles"'
Autor:
Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Léa Luciani, Cécile Baronti, Ornéllie Bernadin, Magali Gilles, Paola Mariela Saba Villarroel, Grégory Moureau, Paul-Rémi Petit, Axelle Dupont, Jacques Izopet, Nassim Kamar, Brigitte Autran, Gilles Paintaud, Sophie Caillard, Amandine le Bourgeois, Christophe Richez, Lionel Couzi, Aliénor Xhaard, Zora Marjanovic, Jerome Avouac, Caroline Jacquet, Dany Anglicheau, Morgane Cheminant, Stéphanie Nguyen, Benjamin Terrier, Jacques Eric Gottenberg, Caroline Besson, Sophie Letrou, Josephine Tine, Joe Miantezila Basilua, Denis Angoulvant, Coralie Tardivon, Gilles Blancho, Guillaume Martin-Blondel, Yazdan Yazdanpanah, France Mentré, Vincent Lévy, Franck Touret, Jérémie Guedj, Xavier de Lamballerie, Antoine Nougairède
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 177, Iss , Pp 116988- (2024)
Therapeutic monoclonal antibodies have been successful in protecting vulnerable populations against SARS-CoV-2. However, their effectiveness has been hampered by the emergence of new variants. To adapt the therapeutic landscape, health authorities ha
Externí odkaz:
https://doaj.org/article/37d8355502934219aae7717aaa15b4b4
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
For handling safely infectious agents, European laboratories must comply with specific EC Directives, national regulations and recommendations from the World Health Organization (WHO). To prevent laboratory acquired infections (LAIs) and pathogens di
Externí odkaz:
https://doaj.org/article/30b5e786815e42c691758633164f77c6
Autor:
Jean-Sélim Driouich, Maxime Cochin, Franck Touret, Paul-Rémi Petit, Magali Gilles, Grégory Moureau, Karine Barthélémy, Caroline Laprie, Thanaporn Wattanakul, Palang Chotsiri, Richard M. Hoglund, Joel Tarning, Laurent Fraisse, Peter Sjö, Charles E. Mowbray, Fanny Escudié, Ivan Scandale, Eric Chatelain, Xavier de Lamballerie, Caroline Solas, Antoine Nougairède
Publikováno v:
EBioMedicine, Vol 82, Iss , Pp 104148- (2022)
Summary: Background: To address the emergence of SARS-CoV-2, multiple clinical trials in humans were rapidly started, including those involving an oral treatment by nitazoxanide, despite no or limited pre-clinical evidence of antiviral efficacy. Meth
Externí odkaz:
https://doaj.org/article/2c868ce6fdee4c09b5bfe87564b64a94
Autor:
Franck Touret, Léa Luciani, Cécile Baronti, Maxime Cochin, Jean-Sélim Driouich, Magali Gilles, Laurence Thirion, Antoine Nougairède, Xavier de Lamballerie
Publikováno v:
mBio, Vol 12, Iss 4 (2021)
ABSTRACT Since its emergence in 2019, circulating populations of the new coronavirus (CoV) continuously acquired genetic diversity. At the end of 2020, a variant named 20I/501Y.V1 (lineage B.1.1.7) emerged and replaced other circulating strains in se
Externí odkaz:
https://doaj.org/article/49609bfe41d84d1ebf5651a0b0d86f6a
Autor:
Franck Touret, Magali Gilles, Raphaelle Klitting, Fabien Aubry, Xavier de Lamballerie, Antoine Nougairède
Publikováno v:
Emerging Microbes and Infections, Vol 7, Iss 1, Pp 1-12 (2018)
Abstract Zika virus (ZIKV) has recently become dispersed throughout the tropics and sub-tropics, causing epidemics associated with congenital disease and neurological complications. There is currently no commercial vaccine for ZIKV. In this study, we
Externí odkaz:
https://doaj.org/article/d2ca378db1b24da992f877fe694de2d0
Autor:
Anne Weiss, Franck Touret, Cecile Baronti, Magali Gilles, Bruno Hoen, Antoine Nougairède, Xavier de Lamballerie, Morten O A Sommer
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260958 (2021)
SARS-CoV-2 variants are emerging with potential increased transmissibility highlighting the great unmet medical need for new therapies. Niclosamide is a potent anti-SARS-CoV-2 agent that has advanced in clinical development. We validate the potent an
Externí odkaz:
https://doaj.org/article/212ecde653b84f1893790a4ab2a5a304
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 9, Pp 2256-2257 (2020)
We spotted severe acute respiratory syndrome coronavirus 2 on polystyrene plastic, aluminum, and glass for 96 hours with and without bovine serum albumin (3 g/L). We observed a steady infectivity (
Externí odkaz:
https://doaj.org/article/cc73e465f2ee45c186bc55dec5d93486
Publikováno v:
Viruses, Vol 12, Iss 7, p 735 (2020)
Standard precautions to minimize the risk of SARS-CoV-2 transmission implies that infected cell cultures and clinical specimens may undergo some sort of inactivation to reduce or abolish infectivity. We evaluated three heat inactivation protocols (56
Externí odkaz:
https://doaj.org/article/95759b481b154bafa26c6672e8c372cd
Autor:
Boris Pastorino, Franck Touret, Magali Gilles, Lea Luciani, Xavier de Lamballerie, Remi N. Charrel
Publikováno v:
Viruses, Vol 12, Iss 6, p 624 (2020)
Clinical samples collected in coronavirus disease 19 (COVID-19), patients are commonly manipulated in biosafety level 2 laboratories for molecular diagnostic purposes. Here, we tested French norm NF-EN-14476+A2 derived from European standard EN-14885
Externí odkaz:
https://doaj.org/article/74a0d516340e4cdc9ed94012a24afb86
Autor:
Jean-Sélim Driouich, Maxime Cochin, Franck Touret, Paul-Rémi Petit, Magali Gilles, Grégory Moureau, Karine Barthélémy, Caroline Laprie, Thanaporn Wattanakul, Palang Chotsiri, Richard M. Hoglund, Joel Tarning, Laurent Fraisse, Peter Sjö, Charles E. Mowbray, Fanny Escudié, Ivan Scandale, Eric Chatelain, Xavier de Lamballerie, Caroline Solas, Antoine Nougairède
To address the emergence of SARS-CoV-2, multiple clinical trials in humans were rapidly started, including those involving an oral treatment by nitazoxanide, despite no or limited pre-clinical evidence of antiviral efficacy.In this work, we present a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df41ae06c9c8f4702f1c8e860c49c6fd
https://ora.ox.ac.uk/objects/uuid:4ea7c3fb-47f4-435c-9e65-01350851c272
https://ora.ox.ac.uk/objects/uuid:4ea7c3fb-47f4-435c-9e65-01350851c272